KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $9.1 million.

  • Oscar Health's Capital Expenditures rose 3289.34% to $9.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $36.4 million, marking a year-over-year increase of 3037.96%. This contributed to the annual value of $36.4 million for FY2025, which is 3037.96% up from last year.
  • Latest data reveals that Oscar Health reported Capital Expenditures of $9.1 million as of Q4 2025, which was up 3289.34% from $9.0 million recorded in Q3 2025.
  • Oscar Health's Capital Expenditures' 5-year high stood at $9.6 million during Q3 2022, with a 5-year trough of $5.6 million in Q2 2023.
  • Over the past 5 years, Oscar Health's median Capital Expenditures value was $7.0 million (recorded in 2022), while the average stood at $7.2 million.
  • In the last 5 years, Oscar Health's Capital Expenditures skyrocketed by 11724.38% in 2021 and then crashed by 3262.97% in 2023.
  • Over the past 5 years, Oscar Health's Capital Expenditures (Quarter) stood at $7.2 million in 2021, then decreased by 1.05% to $7.1 million in 2022, then decreased by 14.42% to $6.1 million in 2023, then grew by 11.75% to $6.8 million in 2024, then soared by 32.89% to $9.1 million in 2025.
  • Its Capital Expenditures was $9.1 million in Q4 2025, compared to $9.0 million in Q3 2025 and $9.3 million in Q2 2025.